APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment.
Alzforum,
Sjödin S, Andersson KK, Mercken M, Zetterberg H, Borghys H, Blennow K, Portelius E.
Sjödin S, Andersson KK, Mercken M, Zetterberg H, Borghys H, Blennow K, Portelius E.
IntroductionAlzheimers disease brains are characterized by extracellular plaques containing the aggregated amyloid 42 (A 42 …